Evidence map›Paper›PMID 39752460›Full record

ArticlePloS one2025

Point prevalence survey of antibiotic use in Mexican secondary care hospitals.

Federico A Zumaya-Estrada, Celia M Alpuche-Aranda, Hilda Ivonne Huerta Icelo, Felipe D Neri-Estrada, Verónica M Calixto Silva, Haydee E Quiroz Escoriza, Jesus Ulises Garza-Ramos, Pedro J Saturno-Hernandez

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Federico A Zumaya-EstradaNational Institute of Public Health of Mexico, Center for Infectious Diseases Research, Cuernavaca, Morelos, Mexico.ORCID 0000-0001-8764-4375
Celia M Alpuche-ArandaNational Institute of Public Health of Mexico, Center for Infectious Diseases Research, Cuernavaca, Morelos, Mexico.
Hilda Ivonne Huerta IceloNational Institute of Public Health of Mexico, Center for Infectious Diseases Research, Cuernavaca, Morelos, Mexico.
Felipe D Neri-EstradaNational Institute of Public Health of Mexico, Center for Infectious Diseases Research, Cuernavaca, Morelos, Mexico.
Verónica M Calixto SilvaPharmacovigilance Unit, General Hospital of Cuernavaca "Dr. José G. Parres", Health Services of Morelos, Cuernavaca, Morelos, Mexico.
Haydee E Quiroz EscorizaDepartment of Teaching, Research and Training, Women's Specialty Hospital, Health Services of Morelos, Yautepec de Zaragoza, Morelos, Mexico.
Jesus Ulises Garza-RamosNational Institute of Public Health of Mexico, Center for Infectious Diseases Research, Cuernavaca, Morelos, Mexico.ORCID 0000-0002-5013-3050
Pedro J Saturno-HernandezNational Institute of Public Health of Mexico, Center for Evaluation and Surveys Research, Cuernavaca, Morelos, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTackling the inertia of growing threat of antimicrobial resistance (AMR) requires changes in how antibiotics are prescribed and utilized. The monitoring of antimicrobial prescribing in hospitals is a critical component in optimizing antibiotic use. Point prevalence surveys (PPSs) enable the surveillance of antibiotic prescribing at the patient level in small hospitals that lack the resources to establish antimicrobial stewardship programs (ASP). In this study, we analyzed antibiotic use at two public secondary care hospitals in Mexico using PPSs.

methodsFollowing WHO methodology, we conducted four cross-sectional PPSs on antibiotic use in two public secondary care facilities in Mexico: two surveys in a women's specialty hospital (H1) and two in a general referral hospital (H2). We collected data from clinical records of all patients with active antibiotic prescriptions (APs) across the medical, surgical, and mixed (MIX) wards, and intensive care units (ICUs). Descriptive statistics were computed to analyze the PPSs data using Stata.

resultsThe PPSs collected data on 127 patients, and 283 active APs. The prevalence of antibiotic use was 60.4% (H1, n = 29/48) and 70.5% (H2, n = 98/139). Antibiotics were more frequently used among patients in the MIX wards (H1: 87.5%, n = 14/16) and ICUs (H2: 90%, n = 9/10). The most frequent patient indications for antibiotic use were medical prophylaxis (H1: 51.7%, n = 15/29), community-acquired infections (H2: 42.9%, n = 42/98), and preoperative prophylaxis (H1: 27.6%, n = 8/29; H2: 23.5%, n = 23/98). The APs were mostly empirical (H1: 97%, n = 64/66; H2: 98.2%, n = 213/217), and parenterally administered (H1: 90.9%, n = 60/66; H2: 96.8%, n = 210/217). Most clinical records lacked documented post-prescription reviews (H1: 82.8%, n = 24/29; H2: 98%, n = 96/98). Preoperative prophylaxis was predominantly administered as multiple doses for more than one day. Penicillins with extended-spectrum (24.2%, n = 16/66), aminoglycosides (22.7%, n = 15/66), and first-generation cephalosporins (16.7%, n = 11/66) were the most prescribed antibiotic classes in H1, while third-generation cephalosporins (35%, n = 76/217), fluoroquinolones (14.3%, n = 31/217), and carbapenems (13.4%, n = 29/217) were the most prescribed in H2. No hospital had formally established ASP.

conclusionsThis study shows high prevalence rates of antibiotic use and variations in commonly prescribed antibiotic classes in public Mexican secondary care hospitals, along with shared practices in broad-spectrum antibiotic prescription. PPS-based surveillance enables the identification of specific targets to optimize antibiotic use according to the healthcare needs of patients in each hospital and facilitates comparative evaluations across hospitals.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipAdolescentAdultAgedCross-Sectional StudiesDrug PrescriptionsFemaleHumansMaleMexicoMiddle AgedPrevalenceSecondary Care CentersSecondary Health CareSurveys and QuestionnairesAnti-Bacterial Agents

Identifiers

PMID39752460
PMCPMC11698459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.